NCT00171405 - A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg | Biotech Hunter

Enrollment

250

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions

Hypertension

Interventions

DRUG

aliskiren

Trial Locations (10)

Investigative Site, East Hanover

Investigative Site, Deurne

Investigative Site, Ste-Fov

Investigative Site, Krassel

Investigative Site, Broni

Investigative Site, Rotterdam

Investigative Site, Lima

Investigative Site, Moscow

Investigative Site, Basel

Investigative Site, London